Stuart Therapeutics, a clinical stage, ophthalmic therapeutic development company, has announced the topline results of the first in human Phase II clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease. The trial The clinical trial, conducted between June and October 2021, was a multi-centre, randomised, controlled, double masked clinical trial to […]